ASRT vs BABA · rev $125.0M vs P/E 20, rev $137.30B
Assertio Therapeutics Inc (ASRT) versus Alibaba Group Holding Ltd (BABA) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
Alibaba Group Holding Ltd (BABA) is a internet retail company listed on US.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported BABA revenue for 2025-03-31 was $137.30B. Net income was $17.93B. Revenue was up 5.3% from 2024-03-31 to 2025-03-31. BABA currently screens at market cap $305.19B and trailing P/E 19.6.
ASRT currently screens at market cap $151.5M. BABA currently screens at market cap $305.19B and trailing P/E 19.6.
Not investment advice. Open the ASRT and BABA stock pages for the full models.
Not investment advice.